The American Journal of Medicine
Volume 123, Issue 2 , Pages 103-110 , February 2010

The Thrombin Hypothesis in ACS: A Disappointing Disconnect between Bench Data and Bedside Clinical Trials

  • Marc Cohen, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Marc Cohen, MD, Division of Cardiology, Newark Beth Israel Medical Center, 201 Lyons Avenue at Osborne Terrace, Newark, NJ 07112

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding: Editorial/writing support for the preparation of this manuscript was funded by sanofi-aventis. The author, however, was fully responsible for all content and received no financial support or other form of compensation related to the development of the article.

 Conflict of Interest: The author received grant support from Aventis Pharmaceuticals, consulting fees from sanofi-aventis and AstraZeneca, and lecture fees from sanofi-aventis, Merck, and Schering.

 Authorship: Author had access to the data and a role in writing the manuscript.

PII: S0002-9343(09)00772-4

doi: 10.1016/j.amjmed.2009.09.001

The American Journal of Medicine
Volume 123, Issue 2 , Pages 103-110 , February 2010

Article Tools

* Image Usage & Resolution